GENinCode Plc (AIM:GENI)
3.400
-0.500 (-12.82%)
At close: Dec 5, 2025
GENinCode Revenue
GENinCode had revenue of 1.60M GBP in the half year ending June 30, 2025, with 68.63% growth. This brings the company's revenue in the last twelve months to 2.91M, up 12.12% year-over-year. In the year 2024, GENinCode had annual revenue of 2.70M with 25.05% growth.
Revenue (ttm)
2.91M
Revenue Growth
+12.12%
P/S Ratio
3.35
Revenue / Employee
69.38K
Employees
42
Market Cap
9.75M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 43.24B |
| GSK plc | 32.17B |
| Haleon | 11.02B |
| Smith & Nephew | 4.33B |
| Convatec Group | 1.72B |
| Hikma Pharmaceuticals | 2.35B |
| HUTCHMED (China) | 439.54M |
| Genus | 672.80M |
GENinCode News
- 2 days ago - AIM Market Roundup: Genincode, Proteome Sciences, Caspian Sunrise - The Armchair Trader
- 2 months ago - Half Year 2025 Genincode PLC Earnings Presentation Transcript - GuruFocus
- 2 months ago - AIM Market Roundup: Mosman Oil, Tekcapital, ECR Minerals - The Armchair Trader
- 2 months ago - AIM Market Roundup: Genincode, Silver Bullet, Focusrite - The Armchair Trader
- 4 months ago - AIM Market Roundup: Westmount Energy, Simec Atlantis, CAP-XX - The Armchair Trader
- 5 months ago - AIM Market Roundup: Coral Products, Bezant Resources, Jarvis Securities - The Armchair Trader
- 11 months ago - AIM Market Roundup: Good Energy, Beacon Energy, Abingdon Health - The Armchair Trader
- 11 months ago - AIM Market Roundup: GENinCode, Empyrean, Watkins Jones - The Armchair Trader